B+
Bull case
20%
Probability
Target price
$0.25
Analysis reference price unavailable
Analysis 2026-09-29 · RankAlpha Sentiment Codex
VVOS
Vivos TherapeuticsFNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Sleep-center services drove Q2 growth and higher gross margin. If patient conversion and service revenue keep rising while operating cash use falls, the turnaround could gain credibility.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Going-concern warning: $1.8 million of cash at June 30 versus $9.2 million of first-half operating cash use. [#10-Q-2026-08-14]
Momentum
93
Value
36
Sentiment
37
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.12 · Bull $0.25 · Bear $0.04Analysis 2026-09-29; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-02 • Vendor: Data Vendor v1
Scores
As of 2026-10-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-29 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-02
Investment thesis
As of 2026-10-02
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-02. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $0.75
Why
Momentum93 · Δ7d -
Value36 · Δ7d +0.0
Sentiment37 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta +0.0.
Contradictions & invalidation
- • Going-concern warning: $1.8 million of cash at June 30 versus $9.2 million of first-half operating cash use. [#10-Q-2026-08-14]
- • Nasdaq stockholders' equity and minimum-bid deficiencies; an extension or cure is not assured. [#10-Q-2026-08-14]
- • The filing states that June cash was insufficient to fund the next twelve months and raises substantial doubt about going concern.
Catalyst clock
2026-10-14
Nasdaq compliance and financing decisions
Lead driver: Value · See fundamentals
Momentum
93
8% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
36
47% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
37
45% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 93.1 / Value 36.5 / Sentiment 36.8
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-29. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$0.12
Analysis reference price unavailable
Analysis 2026-09-29 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$0.04
Analysis reference price unavailable
Analysis 2026-09-29 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-02
Fundamentals (TTM)
As of 2026-10-02
Market Cap
$5.1M
Beta
6.89
Shares Out
33.61M
P/E (TTM) · Derived
-0.1
P/S (TTM)
1.28
P/FCF (TTM) · Derived
-0.10
Rev YoY
+34.9%
EPS YoY
-43.8%
Gross Margin
+53.3%
Op Margin
-107.9%
Net Debt
$11.47M
Current Ratio
0.21
As of 2026-10-02 • Updated nightlySource: Internal modelMethods & Data